Has Giles Scuderi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,654,746 in general payments to Giles Scuderi, MD across 345 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Giles Scuderi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Giles Scuderi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Giles Scuderi, MD

Orthopaedic Surgery · New York, NYNPI 1639113863

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $10,186,353 of the $10,654,746 with a category attached, or 95.6%. Zimmer Biomet accounts for 99.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $5,668,749 and has fallen 99.1% since, to $51,845 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,654,746in general payments, 2019–2025

Across 345 payments — averaging $30,883 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$10.6M
KCI USA, Inc.$27K
Solventum Corporation$17K
Convatec Inc.$7K
Canary Medical USA LLC$2K
Smith+Nephew$308
plus $430 from 3 others

$215,114in research payments, 2019–2025

Across 12 payments — averaging $17,926 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Next Science LLC$106K
Solventum Corporation$55K
KCI USA, Inc.$54K

What the payments were for

Royalty or licence$10,186,35396%
Consulting fees$318,0023%
Speaking & faculty fees$35,0380%
Travel & lodging$16,2940%
Food & beverage$10,4830%
Education$88,5761%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	311	$10,600,668
KCI USA, Inc.	17	$27,090
Solventum Corporation	6	$17,150
Convatec Inc.	2	$7,425
Canary Medical USA LLC	2	$1,675
Smith+Nephew	3	$308
Pacira Therapeutics, Inc.	2	$247
Stryker	1	$169
Johnson & Johnson	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,654,746 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$1,115,242

Medicare patients

1,215

Services billed

30,572

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	160	$7,358
Celecoxib	141	$2,484
Meloxicam	270	$597
Naproxen	55	$439
Ibuprofen	49	$408
Amoxicillin	110	$383
Cyclobenzaprine Hcl	35	$336
Oxycodone Hcl	43	$190
Methylprednisolone	11	$105
Clindamycin Hcl	17	$52
Pantoprazole Sodium	11	$42

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

Anthony RomeoNew York$26.8M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$7.1M
Andrew PearleNew York$6.7M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →